1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENPREX INC
Genprex Inc
XNAS: GNPX
199.4K
XNAS Volume

XNAS 07 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Genprex Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Genprex Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue Genprex Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit Genprex Inc Jun-2026 Quarterly Net Profit is $-4 Million which is growth of 4.9% YoY.

Genprex Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
4.54.53.53.44.744.34.36.5667.88
Operating Profit
-4.5-4.5-3.5-3.4-4.7-4-4.3-4.3-6.5-6-6-7.8-8
-0-0.3-0.5-00000.10.1
Profit Before Tax
-4.5-4.5-3.8-3.8-4.7-4-4.3-4.3-6.5-6-5.9-7.8-8
Tax
-------------
⌄
-4.5-4.5-3.8-3.8-4.7-4-4.3-4.3-6.5-6-5.9-7.8-8
Diluted NI Avail to Com Stockholders Ann.
-4.5-4.5-3.8-3.8-4.7-4-4.3-4.3-6.5-6-5.9-7.8-8
Basic EPS
-9.4-14.1-25.3-110-187-286-438.6-1,353-3,300-4,059-4,136-5,720-6,600
Diluted EPS After ExtraOrdinary
-9.4-14.1-25.3-110-187-286-438.6-1,353-3,300-4,059-4,136-5,720-6,600
Number Of Shares End
0.50.30.20000
Net Income Continuing Discontinued Operations
-4.5-4.5-3.8-3.8-4.7-4-4.3-4.3-6.5-6-5.9-7.8-8
Normalized Income
-4.5-4.5-3.8-3.8-4.7-4-4.3-4.3-6.5-6-5.9-7.8-8
Interest Income
-0---00000.10.1
Interest
--0.30.5---------
Net Interest Income
-0-0.3-0.5-00000.10.1
EBIT
-4.5-4.5-3.5-3.3-4.7-4-4.3-4.3-6.5-6-6-7.8-8
EBITDA
-4.5-4.5-3.5-3.3-4.7-4-4.3-4.3-6.5-6-6-7.8-8
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
-
Profit From Continuing Operations
-4.5-4.5-3.8-3.8-4.7-4-4.3-4.3-6.5-6-5.9-7.8-8
Normalized EBITDA
-4.5-4.5-3.5-3.3-4.7-4-4.3-4.3-6.5-6-6-7.8-8
*All financials are in USD Million and price data in USD

Genprex Inc competitor comparison and performance snapshot within industry

Genprex Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEUTRAL

    Annual Revenue Genprex Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Annual Net Profit Genprex Inc Annual Net Profit is $-16 Million which is growth of 23.1% YoY.

Genprex Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
 
Cost Of Rev. Ann.
-
-
 -----------
Gross Profit Ann.
-
-
 -----------
Operating Exp. Ann.
-13.3%
-2.9%
15.815.521.231.123.819.61810.712.43.34.11.1
Operating Profit Ann.
-
-
-15.8-15.5-21.2-31.1-23.8-19.6-18-10.7-12.4-3.3-4.1-1.1
-
-
 -0.70.10.20.1000-0--
Other Exp. Ann.
-
-
 0---------
PBT Ann.
-
-
-16.5-16.2-21.1-30.9-23.7-19.6-17.9-10.7-12.4-3.3-4.1-1.1
Tax Ann.
-
-
 -----------
⌄
-
-
-16.5-16.2-21.1-30.9-23.7-19.6-17.9-10.7-12.4-3.3-4.1-1.1
Diluted NI Avail to Com Stockholders Ann.
-
-
-16.5-16.2-21.1-30.9-23.7-19.6-17.9-10.7-12.4-3.3-4.1-1.1
EPS Ann.
-
-
 -382.8-5,874-24,816-22,000-18,480-18,327.7-24,381.6-35,758.2-11,196.5-13,960-3,613.9
Diluted EPS Ann.
-
-
 -382.8-5,874-24,816-22,000-18,480-18,327.7-24,381.6-35,758.2-11,196.5-13,960-3,613.9
Number Of Shares End
-
-
 0.20-
Total Exp. Ann.
-13.3%
-2.9%
 15.521.231.123.819.61810.712.43.34.11.1
Net Income Continuing Discontinued Operations Ann.
-
-
-16.5-16.2-21.1-30.9-23.7-19.6-17.9-10.7-12.4-3.3-4.1-1.1
Normalized Income Ann.
-
-
-16.5-16.2-21.1-30.9-23.7-19.6-17.9-10.7-12.4-3.3-4.1-1.1
Interest Income Ann.
-
-
 -0.10.20.10000--
Interest Ann.
-
-
 0.7-----0--
EBITDA Ann.
-
-
-15.8-15.5-21.2-31.1-23.8-19.6-17.9-10.6-12.3-3.3-4.1-1.1
Reconciled Cost Of Rev. Ann.
-
-
 -----------
Reconciled Depr. Ann.
-
-
 0000000
Profit From Continuing Operations Ann.
-
-
-16.5-16.2-21.1-30.9-23.7-19.6-17.9-10.7-12.4-3.3-4.1-1.1
Normalized EBITDA Ann.
-
-
-15.8-15.5-21.2-31.1-23.8-19.6-17.9-10.6-12.3-3.3-4.1-1.1
*All financials are in USD Million and price data in USD
Operating Exp. Ann.
1Y CHG
-26.9%
2Y CAGR
-29.4%
3Y CAGR
-13.3%
5Y CAGR
-2.9%
7Y CAGR
3.2%
10Y CAGR
30.3%
Operating Expenses Annual Cr is falling faster than historical averages.

Genprex Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Genprex Inc Dec-2025 Total Shareholders Fund is $8 Million which is growth of 391.4% YoY.

  • POSITIVE

    Total Assets Genprex Inc Dec-2025 Total Assets is $10 Million which is growth of 146.3% YoY.

Genprex Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-25.9%
-20.1%
10.24.110.725.142.931.43.59.31.31.90.4
⌄
-7.7%
34.5%
2.22.53.32.81.60.50.50.40.80.30
⌄
-28.9%
-23.7%
81.67.422.341.330.938.90.41.60.4
Total Capitalization Ann.
-28.9%
-23.7%
81.67.422.341.330.938.90.41.60.4
Tangible Assets Ann.
-28.2%
-23.4%
81.66.621.640.630.32.58.50.11.40.2
Working Capital Ann.
-30.8%
-27.2%
6.2-0.44.318.737.630.32.58.5-0.61.40.2
Invested Capital Ann.
-28.9%
-23.7%
81.67.422.341.330.938.90.41.60.4
Tangible Book Value Ann.
-28.2%
-23.4%
81.66.621.640.630.32.58.50.11.40.2
Borrowings Ann.
-
-
-----------
Net Debt Ann.
-
-
-----------
Share Issued Ann.
-
-
0.20
Number Of Shares End
-
-
0.20-
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
148.8%
2Y CAGR
-2.4%
3Y CAGR
-25.9%
5Y CAGR
-20.1%
7Y CAGR
1.3%
10Y CAGR
38.2%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-12%
2Y CAGR
-18.4%
3Y CAGR
-7.7%
5Y CAGR
34.5%
7Y CAGR
27.6%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
400%
2Y CAGR
4%
3Y CAGR
-28.9%
5Y CAGR
-23.7%
7Y CAGR
-1.5%
10Y CAGR
34.9%
Total ShareHolders Funds Annual growth is higher than historical averages.

Genprex Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Genprex Inc Book Value Per Share is $18 which is growth of -60.5% YoY.

  • NEUTRAL

    ROE Genprex Inc ROE is 0% which is growth of 0% YoY.

Genprex Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--285.38%-172.62%-69.88%-52.80%-102.82%-166.44%-235.03%-209.09%-356.13%-260.85%
ROE Ann. %
-
-
--467.24%-207.88%-74.71%-54.29%-105.73%-179.00%-265.79%-323.01%-409.95%-272.58%
ROIC %
-
-
--263.9-60.5-27.4-13.2-19.4-74.1-35.6-102.7-61.5-
OPM Ann. %
-
-
-----------
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
-
-
-----------
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-
-
-0.62.17.524.460.63.922.20.25.614.3
Current Ratio Ann.
-
-
-0.82.37.624.768.25.822.80.25.715.3
Interest Coverage Ratio Ann.
-
-
--------324.7-1,752.5--
LT Debt To Equity Ann.
-
-
-----------
*All financials are in USD Million and price data in USD

Genprex Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity Genprex Inc Cash From Operating Activity is $-15 Million which is growth of 10.7% YoY.

  • POSITIVE

    Net Cash Flow Genprex Inc Net Cash Flow is $6 Million which is growth of 221.3% YoY.

Genprex Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
-15.3-17.2-24.7-17.8-14.3-13.9-6.9-6.9-2.2-1.3-0.7
-
-
-0.10.1-0.1-2.3-1-0.1-0.1-0.1-0
-
-12.4%
21.51210.6025.741.61.315.40.82.70.7
Cash Plus Cash Eqv. End Of Year Ann.
-28.1%
-22.2%
7.81.66.72138.627.328.60.21.60.2
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-24.5%
6.2-5.1-14.2-17.711.325.3-6.68.4-1.41.40
Cash Plus Cash Eqv. Begin Of Year Ann.
-65.4%
-4.4%
1.66.72138.627.328.60.21.60.20.2
Income Tax Paid Supplemental Data Ann.
-
-
-----------
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
---0.1-0.1-0.1-2.3-1-0.1-0.1-0.1-0
Issuance Of Capital Stock Ann.
-
-12.4%
21.51210.6025.741.61.315.40.82.70.7
Issuance Of Debt Ann.
-
-
-----------
Repayment Of Debt Ann.
-
-
-----------
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-15.3-17.2-24.8-17.8-14.4-16.3-7.9-7-2.2-1.3-0.7
*All financials are in USD Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
79.2%
2Y CAGR
42.4%
5Y CAGR
-12.4%
7Y CAGR
4.9%
10Y CAGR
40.8%
Cash from Financing Annual Activity growth is stable compared to historical averages.